Auxilius Pharma
United States
- Boston, Massachusetts
- 14/06/2023
- Seed
- $1,000,000
Pharma start-up with a focus on optimizing and further developing well-established medications
- Industry Pharmaceutical Manufacturing
- Website https://www.auxiliuspharma.com/
- LinkedIn https://www.linkedin.com/company/auxilius-pharma/
Related People
Jedrzej Litwiniuk, MHAFounder
United States -
Boston, Massachusetts
CEO at Auxilius Pharma, a value added generic start-up. Healthcare Strategy and Corporate Finance Consultant and Executive. M&A and Investment Professional. Co-founder and Advisory Board Member at Picket Pharmaceuticals, Inc.
Experienced executive with extensive operational and corporate finance knowledge of the healthcare industry. Since 2018 focusing on developing pharmaceutical start-up companies.
Previously I have gained my expertise as outpatient chain M&A manager, venture capital and asset management Investment Director complemented with two years experience as CEO of orthopedics and spine surgery inpatient clinic in Warsaw, Poland and co-founder and CFO of Picket Pharmaceuticals, Inc, New York based complex generic start-up company. CEMS Master diploma holder (equivalent of MBA run by top European Schools of Business). Executive Master of Health Administration at Columbia University, NY.
DISA Technologies, Inc. | $33,000,000 | (May 1, 2026)
Jupid | $840,000 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026)
Creati AI | $20,000,000 | (May 1, 2026)
Manifest OS | $60,000,000 | (May 1, 2026)
Iterative Health | $77,000,000 | (May 1, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Illuminant Surgical | $8,400,000 | (May 1, 2026)
BioOrbit | $13,334,811 | (May 1, 2026)
Parallel Web Systems | $100,000,000 | (Apr 30, 2026)
Fence | $20,000,000 | (Apr 30, 2026)
Certifyde | $2,000,000 | (Apr 30, 2026)